Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    INTELLIGENT BREAST TUMOR DETECTION SYSTEM WITH TEXTURE AND CONTRAST FEATURES

    According to a research report by the World Health Organization (WHO), breast cancer is the most common type of cancer in women, while the mortality rate of breast cancer of females over 40 years old is extremely high. If detected early, it can be treated early, and the mortality rate of breast cancer can be reduced. Meanwhile, the image processing and pattern recognition technology has been adopted to select suspicious regions, provides alerts to assist in doctors' diagnosis, and reduces misdiagnosis rates due to fatigue of doctors, and improves diagnostic accuracy. Hence, this paper proposed an intelligent breast tumor detection system with texture and contrast features. This system consists of three parts: preprocessing, feature extraction, and learning algorithm. The goal of preprocessing is to obtain a good image quality and a real breast area. In the feature extraction, we extract the two features to describe the breast tumor. These features include Laws' Mask features which are the representation of the texture and modification average distance (MAD) feature which is the representation of the contrast. Each region of interest (ROI) image block will be extracted by these two features. And we will extract useful feature from all extracted features. We hope that a small quantity of feature can be used in our proposed system. Next, we use neural network as learning algorithm to detect the tumor with extracted features. Finally, in the experimental results, we use three databases to verify our proposed system, and two radiologists participated in that process and designed final verification study. Thus, we understand from the experimental results that a detection rate as high as 98% can be achieved by using only a few features and the simplest artificial neural network rather than a large number of features and a complex classifier. The success of the system will improve the accuracy of the existing detection methods, assist medical diagnosis, and decrease the time of the judgment effective by doctors.

  • articleNo Access

    AUTOMATIC BREAST CANCER ASSESSMENT IN HER-2/neu IMMUNOHISTOCHEMISTRY

    Breast cancer is the second most common cancer in females, after lung cancer in the world. In Taiwan, there are about 8500 female suffering from breast cancer every year. The incidence of breast cancer has exceeded cervical cancer and has become the most common female cancer. Immunohistochemistry (IHC) image is widely applied to the diagnosis of breast cancer, but it requires a great deal of manpower and time. The IHC images are scoring as {0+, 1+, 2+ and 3+} corresponding to no staining, weak, moderate and strong staining, respectively. With the growing of image processing techniques, computer-assisted technologies are the best solution to reduce the variability of pathologists evaluation and provide highly specific per-cell information. Therefore, in this paper, we proposed an automatic method to assess the grade of breast cancer in IHC images. The proposed method consists of four steps, including ROI extraction, feature extraction, feature selection and a hierarchical SVM classifier. The hierarchical SVM classifier is utilized to score the IHC images into 0+ (no staining), 1+ (weak), 2+ (moderate) and 3+ (strong staining). According to the experimental results, the proposed method can automatically and effectively asses the score of IHC images; it provides important information to help physicians treat breast cancer.